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Background: Ischemic preconditioning induces tolerance against ischemia-reperfusion injury prior a sustained
ischemic insult. In experimental studies, exposure to hyperoxia for a limited time before ischemia induces a
low-grade systemic oxidative stress and evokes an (ischemic) preconditioning-like effect of the myocardium. We
hypothesised that pre-treatment by hyperoxia favours enchanced myocardial protection described by decreased
release of cTn T in the 1st postoperative morning and reduces the release of inflammatory cytokines.
Methods: Forty patients with stable coronary artery disease underwent coronary artery bypass grafting with
cardiopulmonary bypass. They were ventilated with 40 or >96% oxygen for 60 minutes followed by by 33 (18–59)
min normoxia before cardioplegia.
Results: In the 1st postoperative morning concentrations of cTnT did not differ between groups ((0.44 (0.26-0.55)
ng/mL in control and 0.45 (0.37-0.71) ng/mL in hyperoxia group). Sixty minutes after declamping the aorta, ratios of
IL-10/IL-6 (0.73 in controls and 1.47 in hyperoxia, p = 0.03) and IL-10/TNF-α (2.91 and 8.81, resp., p = 0.015) were
significantly drifted towards anti-inflammatory, whereas interleukins 6, 8and TNF-α and interferon-γ showed marked
postoperative rise, but no intergroup differences were found.
Conclusions: Pre-treatment by 60 minutes of hyperoxia did not reduce postoperative leak of cTn T in patients
undergoing coronary artery bypass surgery. In the hyperoxia group higher release of anti-inflammatory IL-10 caused
drifting of IL-10/IL-6 and IL-10/TNF-α towards anti-inflammatory.
Keywords: Coronary artery bypass grafting, Preconditioning, Hyperoxia, Troponin T, Cytokine, Interleukin, Tumor
necrosis factor alfa, Interferon gammaBackground
Over 1 million coronary artery bypass grafting (CABG)
operations are performed annually. In a large majority of
patients the postoperative course is uneventful, i.e. with-
out symptoms of major myocardial injury or systemic
organ dysfunction. But in a small fraction of patients
cardiac surgery results in a perioperative myocardial in-
farction, which is the major complication associated with* Correspondence: inga.karu@regionaalhaigla.ee
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reproduction in any medium, provided the ormorbidity and mortality, or excess systemic inflamma-
tory response manifesting clinically as acute organ dys-
function. The concept of (ischemic) preconditioning-like
cardioprotection induced by pre-treatment with hyper-
oxia has been reviewed recently [1]. Shortly, minimal
concentration of oxygen in the inspired gas mixture
evoking protective effect before subsequent ischemia in
the rat heart is 80% and the most efficient > 95%, with
the duration of 30 minutes for mice and 60 minutes for
rats [2-7]. Hyperoxia improves recovery of postischemic
contractile function, reduces infarct size both in normal
and atherosclerotic hearts of experimental animals,
reduces incidence of ischemia-reperfusion inducedd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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preconditioning-like effect is at least partly explained by
a low-grade oxidative stress due to hyperoxic exposure,
which activates various protective mechanisms (antioxi-
dant enzymes, etc.) in the myocardium. As a conse-
quence ‘readiness’ to cope with the oxidative stress
during reperfusion is achieved.
In the first clinical study investigating the cardiopro-
tective potential of hyperoxia during cardiac surgery, we
employed hyperoxic exposure for about 130 minutes im-
mediately before cardiopulmonary bypass (CPB), but
could not detect protective effect [11]. The absence of
time period between hyperoxic exposure and cardiople-
gia, during which the protective mechanisms could be
activated, could have been one possible explanation for
this negative observation. On that background, we
designed the protocol for the present study, which
includes a normoxic window between hyperoxic expos-
ure and beginning of the CPB.
Cardiac surgery results in intense inflammatory re-
sponse caused predominantly by surgical trauma, CPB
and reperfusion injury. The effect of different cytokines
in the heart is depending on different factors such as
time of exposure and concentration [12,13]. Greater
serum concentrations of tumour necrosis factor (TNF)-α
and lower serum levels of interleukin (IL)-10 have been
associated with increased prevalence of complications
after CPB and may be indicative of a prominent proin-
flammatory state [14].
On that background, we aimed to evaluate cardiopro-
tection conferred by adminisration of > 95% oxygen for 1
hour followed by normoxia up to initiation of CPB.
Based on the previous clinical study and animal experi-
ments we hypothesised that such pre-treatment provides
enhanced myocardial protection described by decreased
release of cardiac troponin T (cTn T) in the 1st post-
operative morning (primary endpoint of the study) and
reduces the release of inflammatory cytokines (second-
ary endpoints of the study). For complex evaluation of
dynamics of the inflammatory response, a spectrum of
pro- and anti-inflammatory cytokines was assessed.
Methods
Patients
The investigation conforms to the principles outlined in
the Declaration of Helsinki. Ethical approval for this
study was provided by the Ethics Review Committee on
Human Research of the University of Tartu and a writ-
ten informed consent was obtained from all patients.
Forty adult patients scheduled for isolated primary elect-
ive CABG with at least 3 distal anastomoses were
included and randomised into the control (n = 20) and
hyperoxia (n = 20) groups. The exclusion criteria were as
follows: (1) preoperative infusion of vasoactive orinotropic medications, (2) diabetes mellitus treated ei-
ther with insulin or oral medications, (3) hepatic, renal
(serum creatinine > 150μmol/L) or pulmonary disease.
All medications, except salicylates were allowed until
the day of surgery.Study protocol
After induction of anesthesia and intubation of the tra-
chea, patients were randomly allocated to receive either
40% or > 96% oxygen for 60 minutes (ventilator: Siemens
KIONi, Siemens-Elema AB, Sweden). Thereafter the
mixture of oxygen and air was adjusted until the begin-
ning of CPB to obtain arterial pO2 levels in the range of
100–150 mmHg. The fraction of oxygen in inspired gas
mixture was continuously monitored by the gas analyser
of the patient monitor Siemens SC9000XL (Dräger Med-
ical System, Inc., Danvers, USA).
Arterial blood gases were analysed (Radiometer ABL
700 series, Radiometer Medical A/S, Copenhagen,
Denmark) 10 and 60 minutes after randomisation and
10 and 60 minutes after the discontinuation of CPB.Anesthesia and operative procedure
Standardised intravenous anesthesia (midazolam, fen-
tanyl, propofol, pancuronium) was used in all cases.
Volatile anaesthetics were not used in order to avoid
the confounding effect of a preconditioning-like state
evoked by these agents. Nitroglycerine infusion (at least
1.0 mg/h) was started after the induction of anesthesia.
CPB was performed with a roller pump (Maquet Critica
Care AB, Solna, Sweden) and a membrane oxygenator
(Maquet Quatrox-I, Hirrlingen, Germany) under mild
hypothermia (nasopharyngeal temperature 35–36°C).
Warm blood cardioplegia was given antegradely into the
aortic root. Infusion was repeated at least once every
15–20 minutes. Distal anastomoses were performed
under a single aortic cross-clamp while proximal anasto-
moses were performed under single side-clamp. After
CPB the pulmonary capillary wedge pressure was kept
above 8 mmHg with the infusion of crystalloid and/or
colloid solutions.Hemodynamic measurements
Thermodilution pulmonary artery catheter was inserted
after induction of anesthesia. Heart rate, mean arterial,
central venous, pulmonary artery and pulmonary capil-
lary wedge pressure and cardiac output were recorded at
baseline (before sternotomy) and 15 minutes, 1, 2, 4, 6,
9, 12 and 18 hours after discontinuation of CPB. Cardiac
index (CI), right and left ventricular stroke work indices
and systemic and pulmonary vascular resistance indices
were calculated using standard formulas.
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Blood was sampled from the radial artery cannula before
induction of anesthesia and 1, 6, 18 and 40 hours after
declamping the aorta. Blood was centrifuged immedi-
ately after sampling and serum stored at −80°C until
analyses.
cTn T was measured using STAT (Roche) electroche-
miluminescence immunoassay on „ECLIA“; Analyzer:
Cobas e 411.
Interleukin-1α, IL-2, IL-4, IL-6, IL-10, TNF-α, and
interferon gamma (IFN-γ) were analyzed with the Cyto-
kine and Growth Factors High-sensitivity Array of the
automated biochip immunoassay system, Evidence In-
vestigator™ (Randox Laboratories Ltd., UK).
Statistical analysis
We chose a difference between means of cTn T values
in the 1st postoperative morning of 0.4 ng/mL as clinic-
ally important. For a significance level (alpha) of 0.05
(two-tailed) and 80% power we calculated that 20
patients in each group were needed.
Patient data were analysed using Student’s t-test or
Fisher’s exact test, as appropriate.
Hemodynamic and normally distributed biochemical
data were evaluated using analysis of variance (ANOVA)
for repeated measures and represented as the mean
(standard deviation). Part of the biochemical data (incl.
the ratios) showed non-normal distribution and were
analysed using non-parametric repeated measures
(Friedman) ANOVA and the Mann–Whitney U-test; the
results are represented as the median (interquartileTable 1 Characteristics of patients, oxygenation and surgical
Variable Controls
(n = 19)
Age (years) 65 (8)
Gender (male/female) 15/5
Preoperative medications
Ca-channel blockers, n (%) 6 (31.5)
Nitrates, n (%) 12 (63)
β-blockers, n (%) 17 (89)
ACE-inhibitors, n (%) 14 (74)
Statins, n (%) 15 (79)
Preoperative ejection fraction (%) 58 (11)
paO2 10 min after intubation (mmHg) 130 (49)
paO2 60 min after intubation (mmHg) 108 (27)
Cross-clamping time (min) 47 (33)
Duration of cardiopulmonary bypass (min) 68 (36)
Number of vessels bypassed 3.3 (0.8)
Need for inotropic support, n (%) 7 (37)
Values are provided as incidence (%) or mean (SD).range). In case of significant Friedman test results, Wil-
coxon Matched Pairs test was used for post hoc analysis.




Patients’ characteristics are given in Table 1. There were
no inter-group differences regarding age of the patients,
ischemic time and number of grafted vessels. Signifi-
cantly higher number of patients in the control group
received calcium channel blocking drugs, otherwise the
preoperative usage of medications did not differ between
groups. Inotropic support (dobutamine as the agent of
first choice) was administered in case of cardiac index
<2.5 L min/m2, systolic blood pressure <90 mmHg and
pulmonary capillary wedge pressure >8 mmHg.
One patient was excluded due to missing hemodynamic
measurements and blood sample at one time point, so
results of 19 patients in the control group were analysed.
All patients experienced an uneventful recovery; i.e.
there was no mortality or serious morbidity in this pa-
tient population.
Myocardial necrosis
Myocardial necrosis was not detectable preoperatively.
In the 1st postoperative morning the concentrations of
cTn T did not differ between groups (0.44 (0.26-0.55)
ng/mL in the control and 0.45 (0.37-0.71) ng/mL in the
hyperoxia group) (Figure 1). No significant differences

















Figure 1 Concentrations of cTn T at baseline, 6 h after
declamping the aorta and in the 1st and 2nd postoperative
mornings (POP). Data are given as median with interquartile range.
** p < 0.01 in comparison with baseline.
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Proinflammatory markers
Values of interleukin-1α (0.16 (0.15) pg/mL in the con-
trol and 0.13 (0.08) pg/mL in the hyperoxia group) and
interleukin-1β (0.83 (0.76) pg/mL, and 0.94 (0.71) pg/
mL, respectively) did neither differ preoperatively be-
tween groups nor change significantly during the study
period. The values of interleukin-2 did not differ be-
tween groups ((1.87 (0.57) pg/mL in controls vs 1.90
(1.02) pg/mL in hyperoxia pre-treated patients) perio-
peratively (data not shown).
Concentrations of IL-6,8, TNF-α and IFN-γ increased
after cardiopulmonary bypass, but this was not affected
by pre-treatment by hyperoxia (Figure 2).Figure 2 Concentrations of proinflammatory cytokines (IL-6 – panel A
after declamping the aorta and in the 1st and 2nd postoperative morn
(interquartile range) – panels C, D. ** p < 0.01 in comparison with baseline,Anti-inflammatory markers
Iinterleukin-4 did not show any systemic changes over
the time (Figure 3, panel A).
Interleukin-10, in contrast, peaked 60 minutes after
declamping the aorta and declined already by the 6th
post-declamping hour in both groups. Still, when com-
pared to baseline, the values remained significantly ele-
vated for 2 postoperative days (Figure 3, panel B).Ratios of pro- and anti-inflammatory markers
Highest IL-10 to IL-6 ratio was detected at 60th minute
after declamping (0.73 in the controls and 1.47 in the
hyperoxia group, p = 0.03). Thereafter the values in
both groups were decreased to even below the base-
line (Figure 4, panel A). IL-10 to TNF-α ratio behaved
in a similar manner, showing maximal values and signifi-
cant difference between groups at 60th minute after
declamping (2.91 in the controls and 8.81 in the hyper-
oxia group, p = 0.015) and decreasing thereafter (Figure 4,
panel B). Higher IL-10 to IL-6 ratio in the hyperoxia
group was mainly caused by higher IL-10 levels.Hemodynamic measurements
Preoperative mean CI was 2.2 (0.4) in the control and
2.1 (0.7) L min/m2 in the hyperoxia group. After CPB
the CI, as well as left and right ventricular stroke work
indices were not significantly different from with the
baseline and no intergroup differences were found., IL-8 – panel B, TNFα – panel B, IFNγ – panel D) at baseline, 6 h
ings (POP). Data are given as mean (SD) – panels A, B and as median
* p< 0.05 in comparison with baseline.
Figure 3 Concentrations of anti-inflammatory cytokines (IL-4 – panel A, IL-10 – panel B) at baseline, 6 h after declamping the aorta
and in the 1st and 2nd postoperative mornings (POP). Data are given as mean (SD). ** p < 0.01 in comparison with baseline, * p < 0.05 in
comparison with baseline.
Karu et al. Journal of Negative Results in BioMedicine 2012, 11:14 Page 5 of 7
http://www.jnrbm.com/content/11/1/14Discussion
Present study demonstrates that pre-treatment with 60
minutes of hyperoxia followed by 33 (18–59) min nor-
moxia before CPB does not afford protection against
myocardial injury (cTn T release or myocardial function)
associated with coronary artery bypass grafting. This is
in accordance with our previous study where a different
protocol of hyperoxic pretreatment was implemented
[11]. We established that surgery was associated with a
well-defined release of systemic inflammatory mediators,
and in patients ventilated with >95% oxygen before CPB
the ratios of IL-10/IL-6 and IL-10/TNF-α were drifted
towards anti-inflammatory. It could be a reflection of
changes in the inflammatory response network/profile
due to pre-treatment with hyperoxia.
By now we have tested two different times of hyper-
oxic exposure in clinical studies – 60 minutes followed
by normoxia in the present and about 130 minutes im-
mediately before CPB in a previous study [11]. We did
not find clinically relevant reduction of myocardial injury
(release of cardiac troponin), although this manipulation
resulted in some changes in the inflammatory profile.
There can be several reasons for that. First, it could be
speculated that in case of modern myocardial protectionFigure 4 Ratio of IL-10/IL-6 (panel A) and IL-10/TNFα (panel B) at bas
postoperative mornings (POP). Data are given as median with interquarttechniques only minimal myocardial injury is caused by
cardioplegic cardiac arrest and there is no need for activa-
tion of intrinsic protective mechanisms. The situation is
different in animal experiments where myocardial pro-
tective techniques are not used and injury is therefore
well described. Although we included patients with at
least 3-vessel CABG surgery, the aortic cross-clamping
time of about 46 minutes could have been too short. Also,
in power analysis we expected reduction of cTn T by 0.4
ng/mLin, which probably overestimates cardioprotective
effect of whatever hypothetical intervention in these par-
ticular patients. To detect a difference of 0.1 ng/mL (the
clinical relevance of which remains questionable), a study
with several hundreds of patients needs to be conducted.
Secondly, in difference from mice and rats, hyperoxic ex-
posure of one or two hours in humans might be too weak
stimulus to activate protective pathways. There is no dir-
ect evidence to support or oppose this idea. Some specu-
lations might be drawn from the inter-species
comparisons of myocardial injury in relation to duration
of ischemia. For example, in rodent models of myocardial
infarction, 30–40 minutes of either regional or global
myocardial ischemia is sufficient to induce an infarct size
of 50% of the area at risk. In the porcine heart,eline, 6 h after declamping the aorta and in the 1st and 2nd
ile range. * p < 0.05 in comparison with baseline.
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dial ischemia is required to achieve equivalent levels of in-
farction. Human myocardial infarcts generally require 90
minutes to become established [15]. Whether these data
can be extrapolated to the exposure time of hyperoxia
that is needed to activate endogenous cardioprotective
mechanisms, is not clear. In addition, it has been shown
recently that in comparison with human broncho-alveolar
fluid proteome, oxidative stress response was selectively
enriched only in mice [16]. Regarding the response to
pretreatment by hyperoxia, interspecies differences in
evoking protective effect have been described even in the
hearts of mice and rats[5]. Thirdly, there is a possibility
that the phenomenon of hyperoxia induced myocardial
protection does not exist in humans at all. In vitro stud-
ies, however, suggest that human myocardium can be pre-
conditioned [17]. Several in vivo surrogate models of
ischaemic preconditioning have showed protective effect -
preinfarction angina, repeated balloon inflations, intermit-
tent aortic cross-clamping. Similar to these, hyperoxia has
been shown to be a preconditioning evoking stimulus
both in rodents and in human in vitro studies [2-10].
One factor that could also have an impact on the
results is the preoperative usage of statins and angioten-
sin converting enzyme (ACE) inhibitors. Statins have
shown to evoke cardioprotective effects both in animal
models of ischemia-reperfusion injury and in clinical
studies (reviewed by Ludman et al. [18]), and have the
ability to reduce IL-6 and IL-8 after coronary sur-
gery [19]. ACE inhibitor treatment is associated with
a reduction of IL-6 response to CABG [20] and
confers added myocardial protection during surgical
revascularisation [21].
Observed activation of inflammation in response to
CPB is well in accordance with previous studies. TNF-α
is a proinflammatory cytokine, which plays a central role
in initiating and sustaining inflammation [22]. It
enhances oxidative stress in adult cardiac myocytes both
by increasing reactive oxygen species generation as well
as by decreasing antioxidants. Overexpression of TNF-α
leads to cell injury due to excessive oxidative stress [23].
IL-10 demonstrates potent anti-inflammatory properties
through inhibiting the production of TNF-α and other
proinflammatory cytokines [24]. It has revealed to pos-
sess antioxidant like properties in situations where oxi-
dative stress is increased [25].
IL-10 has been shown to inhibit the production of re-
active oxygen species in isolated macrophages [25] and
has been suggested to modulate TNF-α mediated,
oxidative-stress- induced acute lung injury [14,26,27].
After elective cardiac surgery the ratio of IL-10/TNF-α
messenger RNA has shown to be an independent pre-
dictor of outcome, and thus IL-10 may have a protective
role after cardiac surgery [28]. Hence, an appropriatebalance between IL-10 and TNF-α may be of crucial im-
portance. In the present study we observed a temporary
increase of IL-10/IL-6 and IL-10/TNF-α ratios in the
hyperoxia pre-treated patients, which suggests a change
of the inflammatory profile towards anti-inflammatory.
This can be a circumambage that hyperoxia may reduce
inflammatory response immediately after CPB. Changes
in immune system occur in 2 phases after cardiac surgery
[29]. The 1st phase represents the pro- and anti-
inflammatory reaction returning to normal by the 3rd
postoperative day. This is the cause of systemic inflamma-
tory response with well known clinical manifestations as
acute organ dysfunctions and failures. The 2nd phase
emerges on postoperative day 5 and is characterised
mainly by anti-inflammatory type of reaction. The synthe-
sis of IFN-γ is significantly reduced after cardiac surgery
and postoperative immunosuppression phenomenon in
cardiac surgical patients has been well described [30].
Conclusion
Pre-treatment by hyperoxia for 60 minutes followed by
normoxia did not reduce postoperative leak of cTn T in
patients undergoing coronary artery bypass surgery, but
drifted ratios of IL-10/IL-6 and IL-10/TNFα towards
anti-inflammatory.
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